Skip to main content
. 2022 Sep 8;14:927009. doi: 10.3389/fnagi.2022.927009

TABLE 2.

Detailed demographic and clinical information of PD patients.

PD (n = 89) PD-N (n = 63) PDD (n = 26) P
Age, years 59.85 ± 10.54 58.19 ± 10.70 63.88 ± 9.14 0.020
Male (n, %) 61 (68.5) 42 (66.7) 19 (73.1) 0.554
Education (n, %) < 0.001
 Junior high school and below 38 (42.7) 19 (30.2) 19 (73.1)
 Senior high school 30 (33.7) 24 (38.1) 6 (23.1)
 College and above 21 (23.6) 20 (31.7) 1 (3.8)
BMI (kg/m2) 24.42 ± 3.40 24.25 ± 3.41 24.82 ± 3.40 0.483
Hypertension (n, %) 24 (27.0) 15 (23.8) 9 (34.6) 0.296
Tremor 42 (47.2) 31 (49.2) 11 (42.3) 0.553
Bradykinesia 79 (88.8) 53 (87.3) 24 (92.3) 0.717
Rigidity 79 (89.8) 58 (93.5) 21 (80.8) 0.117
RBD 37 (41.6) 29 (46.0) 8 (30.8) 0.184
Disease duration, years 3.0 (1.5–5.0) 2.0 (1.5–5.0) 3.25 (2.0–5.25) 0.239
H&Y stage 2.20 ± 0.79 2.10 ± 0.71 2.44 ± 0.95 0.068
UPDRS 45.0 (30.0–75.5) 41.0 (29.0–62.5) 68.5 (38.0–78.75) 0.034
UPDRS part III 30.51 ± 15.95 28.42 ± 15.95 35.32 ± 14.29 0.065
NMSS 27.0 (11.0–47.25) 22.0 (9.75, 44.25) 37.5 (17.75–59.0) 0.144
PDQ-39 23.0 (14.0–46.0) 21.5 (14.0–41.5) 30.0 (11.0–58.0) 0.212
HAMD 6.0 (3.0–11.0) 6.0 (3.0–10.0) 5.0 (3.25–13.25) 0.886
MoCA 23.11 ± 4.27 25.24 ± 2.63 17.96 ± 2.85 < 0.001
OH (n, %) 21 (23.6) 10 (15.9) 11 (42.3) 0.008
OH subtypes (n, %)
 Initial OH 11 (12.3) 4 (6.3) 7 (26.9)
 Classic OH 7 (7.9) 5 (7.9) 2 (7.7)
 Delayed OH 3 (3.4) 1 (1.6) 2 (7.7)

Values are expressed as mean ± SD, median (IQR) or n (%). PD-N, patients with Parkinson’s disease without dementia; PDD, patients with Parkinson’s disease with dementia; BMI, body mass index; RBD, rapid eye movement sleep behavior disorder; H&Y, Hoehn and Yahr Scale; UPDRS, unified Parkinson’s disease rating scale; NMSS, non-Motor Symptoms Scale; PDQ-39, 39-item Parkinson’s disease Questionnaire; HAMD, Hamilton Depression Rating Scale; MoCA, Montreal Cognitive Assessment; OH, orthostatic hypotension.